Intersol Solution
Product Images NDC 0942-9605

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Intersol (NDC 0942-9605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fenwal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6b7800slbl (Export 00)

6b7800slbl (Export 00)
This is a description of an 800 mL InterSol Solution Platelet Additive Solution 3 with Twist-off Port, containing specific quantities of different sodium compounds and water for injection. The instructions state to store at Controlled Room Temperature, protect from freezing, avoid excessive heat, and discard unused portions. It is not for direct intravenous infusion. Manufactured by Fresenius Kabi AG and Fenwal International Inc. with contact details provided for more information.*
FDA Label Image

Symbols6b7800s (Image 01)

Symbols6b7800s (Image 01)
This text provides important symbols and definitions for a medical device or product. It includes guidance on consulting electronic instructions for use, sterilization methods, non-pyrogenic fluid path, warnings against reuse, instructions on not using a compromised sterile barrier system, and reminders about handling fragile items. Additionally, information is given on coding, lot numbers, expiration dates, country of manufacture, manufacturer, and manufacturing facilities. Other details cover handling instructions such as avoiding opening packaging with sharp objects, not venting, information on platelet additive solution, and recycling instructions. The text also includes a disclaimer regarding United States federal law restrictions on sale of the device.*
FDA Label Image

Mf6b7800s (Image 02)

FDA Label Image

Table (Table1)

Table (Table1)
This text provides data from in vitro assessments of leukoreduced platelets derived from the AMICUS Separator, with measurements of various parameters such as Glucose, Lactate, Bicarbonate, Lactate Dehydrogenase, CDE2 Expression, Morphology Score, Hypotonic Shock Response, and Extent of Shape Change. The data includes mean values, standard deviations, and the number of samples for each parameter on different days.*
FDA Label Image

Table (Table2)

Table (Table2)
This is a table showing In Vitro Assessments for Irradiated and Non-Irradiated Platelets obtained from AMICUS separator-derived, leukoreduced platelets. The table includes parameters such as Glucose level, Lactate level, Blood Pressure readings, Bicarbonate level, Lactate Dehydrogenase level, CD62 Expression, Morphology Score, Hypotonic Shock Response, and Extent of Shape Change. The data is presented for both irradiated and non-irradiated platelets on different days.*
FDA Label Image

Table3 (Table3)

Table3 (Table3)
Table 3 provides information on In Vitro Assessments of TRIMA ACCEL-derived, Leukoreduced Platelets. The table displays data for various parameters such as Glucose, Lactate, pCO2, Bicarbonate, Lactate Dehydrogenase, P-selectin, Morphology, Hypotonic Shock Response (HSR), and Extent of Shape Change. The values shown include mean (sd) for each parameter at different time points.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.